(Q40494353)
Statements
GW9662, a potent antagonist of PPARgamma, inhibits growth of breast tumour cells and promotes the anticancer effects of the PPARgamma agonist rosiglitazone, independently of PPARgamma activation (English)
Jill M Seargent
Elisabeth A Yates
8 November 2004
1 reference
1 reference